• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Valera Pharmaceuticals

Anonymous board for Valera Pharmaceuticals
Replies
2
Views
8K
Anonymous
Replies
6
Views
9K
Anonymous
Replies
6
Views
7K
Anonymous
Replies
1
Views
5K
Anonymous